Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2000
08/31/2000WO2000050438A1 Antisense modulation of phospholipase a2 group iv expression
08/31/2000WO2000050437A1 ANTISENSE MODULATION OF Smad2 EXPRESSION
08/31/2000WO2000050092A1 Antisense modulation of smad1 expression
08/31/2000WO2000050091A1 Antisense modulation of akt-2 expression
08/31/2000WO2000050076A1 Adenoviral vectors, proteins and methods for their use
08/31/2000WO2000050075A2 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
08/31/2000WO2000050074A2 Neisserial vaccine compositions and methods
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000050051A2 Reovirus for the treatment of cellular proliferative disorders
08/31/2000WO2000050008A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery
08/31/2000WO2000049937A2 Trpm-2 antisense therapy
08/31/2000WO2000049876A1 System and method for evaluating agents which prevent oxidative damage
08/31/2000WO2000049862A1 Transgenic mollusc and method for constructing the same
08/31/2000WO2000043492A8 Method of site specific labeling of proteins and uses therefor
08/31/2000WO2000036113A3 Extending graft survival by heme oxygenase-i expression induced immunomodulation
08/31/2000WO2000028079A3 Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon
08/31/2000WO2000028040A3 Cloning of rhadinovirus genome and methods for its use
08/31/2000WO2000028038A3 Virulence genes and proteins, and their use
08/31/2000WO2000028029A3 Cell surface glycoproteins
08/31/2000WO2000028023A3 Ischaemia/reperfusion-inducible dna's and proteins
08/31/2000WO2000027425A3 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders
08/31/2000WO2000026390A3 Genes and vectors for conferring herbicide resistance in plants
08/31/2000WO2000026349A3 Recombinant oleandolide polyketide synthase
08/31/2000WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000024903A3 Plant-optimized polynucleotides encoding pesticidal 43f- and 80jj1/130-type proteins
08/31/2000WO2000023472A3 Interferon-beta fusion proteins and uses
08/31/2000WO2000023465A3 Methods and reagents for isolating biologically active peptides
08/31/2000WO2000023112A9 Modulation of gene expression by combination therapy
08/31/2000WO2000022170A9 Metabolic selection methods
08/31/2000WO2000022128A9 Protein conjugates containing multimers of green fluorescent protein
08/31/2000WO2000020601A9 Polyketide synthase enzymes and recombinant dna constructs therefor
08/31/2000WO2000020584A9 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
08/31/2000WO2000018932A9 Receptor based antagonists and methods of making and using
08/31/2000WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor
08/31/2000WO2000018914A3 Novel dkr polypeptides
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000018906A9 Shuffling of codon altered genes
08/31/2000WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses
08/31/2000WO2000018795A9 Compositions and methods for wt1 specific immunotherapy
08/31/2000WO2000017103A3 Inventory control
08/31/2000WO2000014237A3 17 kDa FOAM PROTEIN
08/31/2000WO2000011200A3 Plant expression vectors
08/31/2000WO2000005351A3 Alkaline alpha-galactosidase
08/31/2000DE19952969A1 Aus Pflanzen stammende, Asparagin-spezifische Endoprotease-cDNA und -Gen Plant-derived, asparagine-specific endoprotease cDNA and gene
08/31/2000DE19908423A1 An der Entwicklung des ZNS beteiligtes Protein (TP) The development of the CNS involved protein (TP)
08/31/2000DE19904716A1 Vorrichtung zum selektiven Temperieren einzelner Behältnisse Means for selectively controlling the temperature of individual containers
08/31/2000DE19858005A1 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles
08/31/2000DE19811618C1 Ribozym codierende DNA und ein Oligonucleotidsubstrat enthaltende Zusammensetzung und Verfahren zur Messung von Transkriptionsraten Ribozyme encoding DNA and oligonucleotide substrate containing a composition and method for the measurement of transcription rates
08/31/2000CA2850318A1 Trpm-2 antisense therapy
08/31/2000CA2400922A1 Diagnostic and screening method for male infertility
08/31/2000CA2371928A1 Neisserial vaccine compositions and methods
08/31/2000CA2371890A1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
08/31/2000CA2371814A1 Trpm-2 antisense therapy
08/31/2000CA2369002A1 Methods for purifying dna using immobilized capture probes
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2365101A1 Beta-tubulin autoantibody in meniere's disease and other inner ear diseases and a diagnostic method
08/31/2000CA2365026A1 Virus vector
08/31/2000CA2365019A1 Novel polypeptide
08/31/2000CA2364966A1 Genes encoding insect odorant receptors and uses thereof
08/31/2000CA2364925A1 Monkey gonadotropin releasing hormone receptor
08/31/2000CA2363829A1 Haemophilus antigen
08/31/2000CA2363816A1 Dna sequence of a protein that is similar to fkbp
08/31/2000CA2363794A1 14273 receptor, a novel g-protein coupled receptor
08/31/2000CA2363714A1 Avermectin aglycon synthase genes
08/31/2000CA2363707A1 Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection
08/31/2000CA2363704A1 Expressing gp140 fragment of primary hiv-1 isolate
08/31/2000CA2363697A1 Rational selection of peptides presumed to have a specific function derived from identified nucleotide or peptide sequences
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363605A1 Androgen-induced suppressor of cell proliferation and uses thereof
08/31/2000CA2363601A1 Carbohydrate epitope mimic peptides and uses thereof
08/31/2000CA2363599A1 Novel adc polynucleotides and polypeptides, uses thereof including methods for improving seeds
08/31/2000CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000CA2363106A1 Mdm interacting protein and methods of use thereof
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362904A1 System and method for evaluating agents which prevent oxidative damage
08/31/2000CA2362585A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage
08/31/2000CA2362552A1 Maize adenosine deaminase cdna and uses thereof
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/31/2000CA2362520A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
08/31/2000CA2362203A1 Isolation and characterization of a n. crassa silencing gene and uses thereof
08/31/2000CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
08/31/2000CA2361743A1 Genes associated with diseases of the colon
08/31/2000CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/31/2000CA2360847A1 Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells
08/30/2000EP1031628A1 Process for the production of protease inhibitors
08/30/2000EP1031627A1 Beta-carotene 15,15'-dioxygenase
08/30/2000EP1031626A1 Method for stabilising and/or isolating nucleic acids
08/30/2000EP1031625A2 Method for enhancing activity to regenerate electron acceptor for oxidoreductase in microorganism capable of producing said oxidoreductase, and use of microorganism prepared by said method
08/30/2000EP1031578A2 High purity albumin production by a multistep process
08/30/2000EP1031577A2 Transformed Brassica plant
08/30/2000EP1031037A1 Improvements in or relating to detection of molecules in samples
08/30/2000EP1030936A2 Methods and compositions for detection of specific nucleotide sequences
08/30/2000EP1030935A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
08/30/2000EP1030930A1 Efficient construction of vectors for gene targeting using phage-plasmid recombination
08/30/2000EP1030929A1 Transfection and transfer of male germ cells for generation of transgenic species
08/30/2000EP1030928A1 Development of viruses resistant to inactivation by the human complement system
08/30/2000EP1030927A1 Expression plasmids for multiepitope nucleic acid-based vaccines
08/30/2000EP1030926A2 Transgenic models of inflammatory disease
08/30/2000EP1030925A1 The translation enhancer element of the human amyloid precursor protein gene
1 ... 3192 3193 3194 3195 3196 3197 3198 3199 3200 3201 3202 3203 3204 3205 3206 3207 3208 3209 3210 3211 3212 ... 4023